Zai Lab (ZLAB) Earnings Date & Reports

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ZLAB is expected to report earnings to rise 580.50% to -54 cents per share on May 13

Q1'25

Est.

$-0.54

Q4'24

Beat

by $0.65

Q3'24

Beat

by $0.73

Q2'24

Missed

by $0.11

Q1'24

Beat

by $0.88

The last earnings report on February 27 showed earnings per share of -7 cents, beating the estimate of -73 cents. With 319.10K shares outstanding, the current market capitalization sits at 3.97B.

View a ticker or compare two or three

Compare

ZLAB